Developments in autoimmune channelopathies

Autoimmunity Reviews

Volumn 12, Issue 6, 2013, Pages 678-681

  Vincent, Angela ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Autoantibodies; Autoimmune encephalitis; Demyelination; Devic's disease; Encephalopathy; Limbic encephalitis; Neuromyelitis optica

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR ANTIBODY; AMPA RECEPTOR ANTIBODY; AQUAPORIN 4 ANTIBODY; CHLORPHENIRAMINE MALEATE PLUS PHENYLEPHRINE; GLUTAMATE DECARBOXYLASE ANTIBODY; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

AUTOIMMUNE CHANNELOPATHY; AUTOIMMUNE DISEASE; BRAIN DISEASE; CHANNELOPATHY; DEMYELINATION; ENCEPHALITIS; HUMAN; MORVAN SYNDROME; MYELOOPTIC NEUROPATHY; MYOCLONUS; PARANEOPLASTIC NEUROPATHY; PROGRESSIVE ENCEPHALOMYELOPATHY; REVIEW; RIGIDITY; SPINAL CORD LESION; STIFF MAN SYNDROME;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; CHANNELOPATHIES; ENCEPHALITIS; HUMANS; NEUROMYELITIS OPTICA; SYRINGOMYELIA;

EID: 84877068044     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2012.10.016     Document Type: Review

References (20)

1. Vincent A., Bien C.G., Irani S.R., Waters P. Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol 2011, 10:759-772.
2. Zuliani L., Graus F., Giometto B., Bien C.G., Vincent A. Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition. J Neurol Neurosurg Psychiatry 2012, 83:638-645.
3. Vincent A., Buckley C., Schott J.M., Baker I., Dewar B.K., Detert N., et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004, 127:701-712.
4. Irani S.R., Michell A.W., Lang B., Pettingill P., Waters P., Johnson M.R., et al. Faciobrachial dystonic seizures precede Lgi1-antibody limbic encephalitis. Ann Neurol 2011, 69:892-900.
5. Irani S.R., Alexander S., Waters P., et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010, 133:2734-2748.
6. Lai M., Huijbers M.G., Lancaster E., Graus F., Bataller L., Balice-Gordon R., et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010, 9:776-785.
7. Malter M.P., Helmstaedter C., Urbach H., Vincent A., Bien C.G. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 2010, 67:470-478.
8. Dalmau J., Lancaster E., Martinez-Hernandez E., Rosenfeld M.R., Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011, 10:63-74.
9. Irani S.R., Bera K., Waters P., Zuliani L., Maxwell S., Zandi M.S., et al. N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010, 133:1655-1667.
10. Florance N.R., Davis R.L., Lam C., Szperka C., Zhou L., Ahmad S., et al. Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009, 66:11-18.
11. Dale R.C., Irani S.R., Brilot F., Pillai S., Webster R., Gill D., et al. N-methyl-d-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica. Ann Neurol 2009, 66:704-709.
12. Irani S.R., Pettingill P., Kleopa K.A., Schiza N., Waters P., et al. Morvan syndrome clinical and serological observations in 29 cases. Ann Neurol 2012, 72:241-255.
13. Meinck H.M., Thompson P.D. Stiff man syndrome and related conditions. Mov Disord 2002, 17:853-866.
14. Hutchinson M., Waters P., McHugh J., et al. Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology 2008, 71:1291-1292.
15. Mas N., Saiz A., Leite M.I., Waters P., Baron M., Castaño D., et al. Anti-glycine-receptor encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry 2011, 82:1399-1401.
16. Clerinx K., Breban T., Schrooten M., Leite M.I., Vincent A., Verschakelen J., et al. Progressive encephalomyelitis with rigidity and myoclonus (PERM): resolution after thymectomy. Neurology 2011, 76:303-304.
17. Jarius S., Wildemann B. AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol 2010, 6:383-392.
18. Lennon V.A., Kryzer T.J., Pittock S.J., Verkman A.S., Hinson S.R. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005, 202:473-477.
19. Pröbstel A.K., Dornmair K., Bittner R., Sperl P., Jenne D., Magalhaes S., et al. Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology 2011, 77:580-588.
20. Waters P.J., McKeon A., Leite M.I., Rajasekharan S., Lennon V.A., Villalobos A., et al. Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology 2012, 78:665-667.